Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
6th grade Good
|
|
New words:
acute, Allergy, amendment, antibiotic, anticipated, APB, applying, attained, axetil, bacterial, biotechnology, building, Bulletin, calendar, cancelable, Ceftin, cefuroxime, cephalosporin, commercialization, commitment, Dedicated, Deferral, demand, Disease, dosage, enabling, event, FASB, fill, FIN, Glaxo, guidance, Health, intellectual, July, largest, launch, LCV, LifeCycle, liquidity, long, maintain, manufacture, media, Medical, minimum, national, notice, October, Opinion, oral, order, original, originally, outsource, ownership, Partnership, party, peer, Prevention, qualitative, quantitative, recommended, recommending, Recruitment, regulatory, relevant, respiratory, SAB, SEC, slower, specific, Standard, standing, study, Subsequently, subsidiary, Suspension, Tactical, team, treatment, Wellcome, wholly, world, written
Removed:
commenced, consummated, dinner, embedded, President, rapidly, released, symposia
Filing tables
Filing exhibits
IDXG similar filings
External links